CTLA4 and ocular melanoma: Recent studies have investigated vaccines, adoptive cell transfer and monoclonal antibodies targeting canine PD‐1/PD‐L1 and CTLA‐4 for OM in dogs [11, 12, 13, 14, 15, 16, 17, 18].